Literature DB >> 31723025

Naturally Occurring and Engineered Alphaviruses Sensitive to Double-Stranded-RNA-Activated Protein Kinase Show Restricted Translation in Mammalian Cells, Increased Sensitivity to Interferon, and Marked Oncotropism.

René Toribio1, Irene Díaz-López2, Juan José Berlanga2, Francisca Molina-Jiménez3,4, Pedro Majano3,4, Iván Ventoso5.   

Abstract

Alphaviruses are insect-borne viruses that alternate between replication in mosquitoes and vertebrate species. Adaptation of some alphaviruses to vertebrate hosts has involved the acquisition of an RNA structure (downstream loop [DLP]) in viral subgenomic mRNAs that confers translational resistance to protein kinase (PKR)-mediated eIF2α phosphorylation. Here, we found that, in addition to promoting eIF2-independent translation of viral subgenomic mRNAs, presence of the DLP structure also increased the resistance of alphavirus to type I interferon (IFN). Aura virus (AURAV), an ecologically isolated relative of Sindbis virus (SV) that is poorly adapted to replication in vertebrate cells, displayed a nonfunctional DLP structure and dramatic sensitivity to type I IFN. Our data suggest that an increased resistance to IFN emerged during translational adaptation of alphavirus mRNA to vertebrate hosts, reinforcing the role that double-stranded RNA (dsRNA)-activated protein kinase (PKR) plays as both a constitutive and IFN-induced antiviral effector. Interestingly, a mutant SV lacking the DLP structure (SV-ΔDLP) and AURAV both showed a marked oncotropism for certain tumor cell lines that have defects in PKR expression and/or activation. AURAV selectively replicated in and killed some cell lines derived from human hepatocarcinoma (HCC) that lacked PKR response to infection or poly(I·C) transfection. The oncolytic activities of SV-ΔDLP and AURAV were also confirmed using tumor xenografts in mice, showing tumor regression activities comparable to wild-type SV. Our data show that translation of alphavirus subgenomic mRNAs plays a central role in IFN susceptibility and cell tropism, suggesting an unanticipated oncolytic potential that some naive arboviruses may have in virotherapy.IMPORTANCE Interferons (IFNs) induce the expression of a number of antiviral genes that protect the cells of vertebrates against viruses and other microbes. The susceptibility of cells to viruses greatly depends on the level and activity of these antiviral effectors but also on the ability of viruses to counteract this antiviral response. Here, we found that the level of one of the main IFN effectors in the cell, the dsRNA-activated protein kinase (PKR), greatly determines the permissiveness of cells to alphaviruses that lack mechanisms to counteract its activation. These naive viruses also showed a hypersensitivity to IFN, suggesting that acquisition of IFN resistance (even partial) has probably been involved in expanding the host range of alphaviruses in the past. Interestingly, some of these naive viruses showed a marked oncotropism for some tumor cell lines derived from human hepatocarcinoma (HCC), opening the possibility of their use in oncolytic therapy to treat human tumors.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  PKR; RNA structure; arbovirus; interferons; oncolytic viruses; translation

Year:  2020        PMID: 31723025      PMCID: PMC7000984          DOI: 10.1128/JVI.01630-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Inhibition of host translation by virus infection in vivo.

Authors:  René Toribio; Iván Ventoso
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Adaptive changes in alphavirus mRNA translation allowed colonization of vertebrate hosts.

Authors:  Iván Ventoso
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

Review 3.  Protein kinase R and its cellular regulators in cancer: An active player or a surveillant?

Authors:  Yong Sun Lee; Nawapol Kunkeaw; Yeon-Su Lee
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-06-23       Impact factor: 9.957

4.  Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.

Authors:  Markus J V Vähä-Koskela; Janne P Kallio; Linda C Jansson; Jari E Heikkilä; Vasily A Zakhartchenko; Markku A Kallajoki; Veli-Matti Kähäri; Ari E Hinkkanen
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

5.  Loss of PKR activity in chronic lymphocytic leukemia.

Authors:  Su Ing Hii; Lani Hardy; Tania Crough; Elizabeth J Payne; Karen Grimmett; Devinder Gill; Nigel A J McMillan
Journal:  Int J Cancer       Date:  2004-04-10       Impact factor: 7.396

6.  Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways.

Authors:  Chad Myskiw; Janilyn Arsenio; Rebekah van Bruggen; Yvon Deschambault; Jingxin Cao
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

7.  Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers.

Authors:  Yuan Lin; Haipeng Zhang; Jiankai Liang; Kai Li; Wenbo Zhu; Liwu Fu; Fang Wang; Xiaoke Zheng; Huijuan Shi; Sihan Wu; Xiao Xiao; Lijun Chen; Lipeng Tang; Min Yan; Xiaoxiao Yang; Yaqian Tan; Pengxin Qiu; Yijun Huang; Wei Yin; Xinwen Su; Haiyan Hu; Jun Hu; Guangmei Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

8.  Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain.

Authors:  P R Romano; F Zhang; S L Tan; M T Garcia-Barrio; M G Katze; T E Dever; A G Hinnebusch
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

9.  Systemic tumor targeting and killing by Sindbis viral vectors.

Authors:  Jen-Chieh Tseng; Brandi Levin; Alicia Hurtado; Herman Yee; Ignacio Perez de Castro; Maria Jimenez; Peter Shamamian; Ruzhong Jin; Richard P Novick; Angel Pellicer; Daniel Meruelo
Journal:  Nat Biotechnol       Date:  2003-11-30       Impact factor: 54.908

Review 10.  Roles of protein kinase R in cancer: Potential as a therapeutic target.

Authors:  Takao Watanabe; Takeshi Imamura; Yoichi Hiasa
Journal:  Cancer Sci       Date:  2018-03-23       Impact factor: 6.716

View more
  1 in total

Review 1.  De-Coding the Contributions of the Viral RNAs to Alphaviral Pathogenesis.

Authors:  Autumn T LaPointe; Kevin J Sokoloski
Journal:  Pathogens       Date:  2021-06-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.